|
1.1.1 BIOLOGIE - GÉNOME - MÉTASTASES
|
|
|
|
3.1 PRÉVENTION - TABAC
|
|
|
Philip Morris drew up plan for £1bn tobacco transition fund [The Guardian]
|
|
|
|
|
|
Philip Morris International (PMI), one of the world’s biggest tobacco companies, drew up plans for a £1bn tobacco transition fund in the UK to be spent by local authorities and Public Health England on persuading smokers to give up cigarettes in favour of alternatives such as its “heat not burn” smokeless tobacco product, IQOS, leaked documents reveal.
|
|
|
|
|
|
|
|
|
3.1.1 PRÉVENTION - TABAC - E-CIGS
|
|
|
|
|
3.3 PRÉVENTION - VACCINS
|
|
|
|
|
4.1 DÉP., DIAG. & PRONO. - PROSTATE
|
|
|
|
4.5 DÉP., DIAG. & PRONO. - COLORECTAL
|
|
|
|
4.9 DÉP., DIAG. & PRONO. - SEIN
|
|
|
|
5.1 TRAITEMENTS - PRÉ-CLINIQUE
|
|
|
|
|
|
5.10 TRAITEMENTS - ESSAIS
|
|
|
|
5.12 IMMUNOTHÉRAPIES
|
|
|
|
5.12.13 IMMUNOTHÉRAPIES - BIOMARQUEURS
|
|
|
|
5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES
|
|
|
Hidden Costs of CAR T-Cell Therapy [Medscape]
|
|
|
|
|
|
For all the talk about the steep costs of CAR T-cell therapy and how to pay for it, comparatively little attention has been paid to the considerable financial hardships the recipients and their families face, even when insurance and reimbursement are taken into account, according to Meghan Gutierrez, chief executive officer of the Lymphoma Research Foundation.
|
|
|
|
|
|
|
5.12.6 IMMUNOTHÉRAPIES - AMM
|
|
|
|
5.17 TRAITEMENTS - RADIOTHÉRAPIE
|
|
|
|
5.2 PHARMA
|
|
|
|
|
|
5.2.3 PHARMA - ÉCONOMIE
|
|
|
|
|
5.2.6 PHARMA - BIOTECH
|
|
|
|
5.4 TRAITEMENTS - ECONOMIE
|
|
|
|
|
6.1 OBSERVATION
|
|
|
|
6.10 POLITIQUES
|
|
|
|
6.7.1 IA/BIOINFORMATIQUE
|
|
|